Alkermes (ALKS) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Alkermes (ALKS) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -99.56% |
| Mar 31, 2026 | -107.57% |
| Dec 31, 2025 | 108.23% |
| Sep 30, 2025 | 96.24% |
| Jun 30, 2025 | 93.70% |
| Mar 31, 2025 | -23.85% |
| Dec 31, 2024 | -857.64% |
| Sep 30, 2024 | 17.56% |
| Jun 30, 2024 | -62.69% |
| Mar 31, 2024 | 449.16% |
| Dec 31, 2023 | -68.70% |
| Sep 30, 2023 | 210.20% |
| Jun 30, 2023 | 746.25% |
| Mar 31, 2023 | 65.66% |
| Dec 31, 2022 | 123.99% |
| Sep 30, 2022 | -201.61% |
| Jun 30, 2022 | -862.07% |
| Mar 31, 2022 | -45.98% |
| Dec 31, 2021 | -3,026.59% |
| Sep 30, 2021 | -109.43% |